Chronic Idiopathic Constipation (CIC) Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
SUMMARY
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Chronic Idiopathic Constipation (CIC) Drugs market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Chronic Idiopathic Constipation (CIC) Drugs market segmented into
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Chronic Idiopathic Constipation (CIC) Drugs market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Chronic Idiopathic Constipation (CIC) Drugs market segmented into
- Lubiprostone
- Linaclotide
- Others
- Hospitals & Clinics
- Ambulatory Surgical Centres
- Long Term Care Centres
- Others
- North America [U.S., Canada, Mexico]
- Europe [Germany, UK, France, Italy, Rest of Europe]
- Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
- South America [Brazil, Argentina, Rest of Latin America]
- Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
- Actavis
- Chugai Pharmaceutical
- Ferring International Center
- Synergy Pharmaceuticals
- Pfizer
- GlaxoSmithKline
- Roche Holding
- Sanofi
- Bayer
- Salix Pharmaceuticals
- Sucampo Pharmaceuticals
- Ironwood Pharmaceuticals
- Progenics Pharmaceuticals
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CHRONIC IDIOPATHIC CONSTIPATION (CIC) DRUGS INDUSTRY
2.1 Summary about Chronic Idiopathic Constipation (CIC) Drugs Industry
2.2 Chronic Idiopathic Constipation (CIC) Drugs Market Trends
2.2.1 Chronic Idiopathic Constipation (CIC) Drugs Production & Consumption Trends
2.2.2 Chronic Idiopathic Constipation (CIC) Drugs Demand Structure Trends
2.3 Chronic Idiopathic Constipation (CIC) Drugs Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Lubiprostone
4.2.2 Linaclotide
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals & Clinics
4.3.2 Ambulatory Surgical Centres
4.3.3 Long Term Care Centres
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Lubiprostone
5.2.2 Linaclotide
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals & Clinics
5.3.2 Ambulatory Surgical Centres
5.3.3 Long Term Care Centres
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Lubiprostone
6.2.2 Linaclotide
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals & Clinics
6.3.2 Ambulatory Surgical Centres
6.3.3 Long Term Care Centres
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Lubiprostone
7.2.2 Linaclotide
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals & Clinics
7.3.2 Ambulatory Surgical Centres
7.3.3 Long Term Care Centres
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Lubiprostone
8.2.2 Linaclotide
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals & Clinics
8.3.2 Ambulatory Surgical Centres
8.3.3 Long Term Care Centres
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Lubiprostone
9.2.2 Linaclotide
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals & Clinics
9.3.2 Ambulatory Surgical Centres
9.3.3 Long Term Care Centres
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Actavis
10.1.2 Chugai Pharmaceutical
10.1.3 Ferring International Center
10.1.4 Synergy Pharmaceuticals
10.1.5 Pfizer
10.1.6 GlaxoSmithKline
10.1.7 Roche Holding
10.1.8 Sanofi
10.1.9 Bayer
10.1.10 Salix Pharmaceuticals
10.1.11 Sucampo Pharmaceuticals
10.1.12 Ironwood Pharmaceuticals
10.1.13 Progenics Pharmaceuticals
10.2 Chronic Idiopathic Constipation (CIC) Drugs Sales Date of Major Players (2017-2020e)
10.2.1 Actavis
10.2.2 Chugai Pharmaceutical
10.2.3 Ferring International Center
10.2.4 Synergy Pharmaceuticals
10.2.5 Pfizer
10.2.6 GlaxoSmithKline
10.2.7 Roche Holding
10.2.8 Sanofi
10.2.9 Bayer
10.2.10 Salix Pharmaceuticals
10.2.11 Sucampo Pharmaceuticals
10.2.12 Ironwood Pharmaceuticals
10.2.13 Progenics Pharmaceuticals
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CHRONIC IDIOPATHIC CONSTIPATION (CIC) DRUGS INDUSTRY
2.1 Summary about Chronic Idiopathic Constipation (CIC) Drugs Industry
2.2 Chronic Idiopathic Constipation (CIC) Drugs Market Trends
2.2.1 Chronic Idiopathic Constipation (CIC) Drugs Production & Consumption Trends
2.2.2 Chronic Idiopathic Constipation (CIC) Drugs Demand Structure Trends
2.3 Chronic Idiopathic Constipation (CIC) Drugs Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Lubiprostone
4.2.2 Linaclotide
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals & Clinics
4.3.2 Ambulatory Surgical Centres
4.3.3 Long Term Care Centres
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Lubiprostone
5.2.2 Linaclotide
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals & Clinics
5.3.2 Ambulatory Surgical Centres
5.3.3 Long Term Care Centres
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Lubiprostone
6.2.2 Linaclotide
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals & Clinics
6.3.2 Ambulatory Surgical Centres
6.3.3 Long Term Care Centres
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Lubiprostone
7.2.2 Linaclotide
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals & Clinics
7.3.2 Ambulatory Surgical Centres
7.3.3 Long Term Care Centres
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Lubiprostone
8.2.2 Linaclotide
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals & Clinics
8.3.2 Ambulatory Surgical Centres
8.3.3 Long Term Care Centres
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Lubiprostone
9.2.2 Linaclotide
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals & Clinics
9.3.2 Ambulatory Surgical Centres
9.3.3 Long Term Care Centres
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Actavis
10.1.2 Chugai Pharmaceutical
10.1.3 Ferring International Center
10.1.4 Synergy Pharmaceuticals
10.1.5 Pfizer
10.1.6 GlaxoSmithKline
10.1.7 Roche Holding
10.1.8 Sanofi
10.1.9 Bayer
10.1.10 Salix Pharmaceuticals
10.1.11 Sucampo Pharmaceuticals
10.1.12 Ironwood Pharmaceuticals
10.1.13 Progenics Pharmaceuticals
10.2 Chronic Idiopathic Constipation (CIC) Drugs Sales Date of Major Players (2017-2020e)
10.2.1 Actavis
10.2.2 Chugai Pharmaceutical
10.2.3 Ferring International Center
10.2.4 Synergy Pharmaceuticals
10.2.5 Pfizer
10.2.6 GlaxoSmithKline
10.2.7 Roche Holding
10.2.8 Sanofi
10.2.9 Bayer
10.2.10 Salix Pharmaceuticals
10.2.11 Sucampo Pharmaceuticals
10.2.12 Ironwood Pharmaceuticals
10.2.13 Progenics Pharmaceuticals
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
LIST OF TABLES
Table Chronic Idiopathic Constipation (CIC) Drugs Product Type Overview
Table Chronic Idiopathic Constipation (CIC) Drugs Product Type Market Share List
Table Chronic Idiopathic Constipation (CIC) Drugs Product Type of Major Players
Table Brief Introduction of Actavis
Table Brief Introduction of Chugai Pharmaceutical
Table Brief Introduction of Ferring International Center
Table Brief Introduction of Synergy Pharmaceuticals
Table Brief Introduction of Pfizer
Table Brief Introduction of GlaxoSmithKline
Table Brief Introduction of Roche Holding
Table Brief Introduction of Sanofi
Table Brief Introduction of Bayer
Table Brief Introduction of Salix Pharmaceuticals
Table Brief Introduction of Sucampo Pharmaceuticals
Table Brief Introduction of Ironwood Pharmaceuticals
Table Brief Introduction of Progenics Pharmaceuticals
Table Products & Services of Actavis
Table Products & Services of Chugai Pharmaceutical
Table Products & Services of Ferring International Center
Table Products & Services of Synergy Pharmaceuticals
Table Products & Services of Pfizer
Table Products & Services of GlaxoSmithKline
Table Products & Services of Roche Holding
Table Products & Services of Sanofi
Table Products & Services of Bayer
Table Products & Services of Salix Pharmaceuticals
Table Products & Services of Sucampo Pharmaceuticals
Table Products & Services of Ironwood Pharmaceuticals
Table Products & Services of Progenics Pharmaceuticals
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Chronic Idiopathic Constipation (CIC) Drugs Market Forecast (Million USD) by Region 2021f-2026f
Table Global Chronic Idiopathic Constipation (CIC) Drugs Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Chronic Idiopathic Constipation (CIC) Drugs Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Chronic Idiopathic Constipation (CIC) Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f
Table Chronic Idiopathic Constipation (CIC) Drugs Product Type Overview
Table Chronic Idiopathic Constipation (CIC) Drugs Product Type Market Share List
Table Chronic Idiopathic Constipation (CIC) Drugs Product Type of Major Players
Table Brief Introduction of Actavis
Table Brief Introduction of Chugai Pharmaceutical
Table Brief Introduction of Ferring International Center
Table Brief Introduction of Synergy Pharmaceuticals
Table Brief Introduction of Pfizer
Table Brief Introduction of GlaxoSmithKline
Table Brief Introduction of Roche Holding
Table Brief Introduction of Sanofi
Table Brief Introduction of Bayer
Table Brief Introduction of Salix Pharmaceuticals
Table Brief Introduction of Sucampo Pharmaceuticals
Table Brief Introduction of Ironwood Pharmaceuticals
Table Brief Introduction of Progenics Pharmaceuticals
Table Products & Services of Actavis
Table Products & Services of Chugai Pharmaceutical
Table Products & Services of Ferring International Center
Table Products & Services of Synergy Pharmaceuticals
Table Products & Services of Pfizer
Table Products & Services of GlaxoSmithKline
Table Products & Services of Roche Holding
Table Products & Services of Sanofi
Table Products & Services of Bayer
Table Products & Services of Salix Pharmaceuticals
Table Products & Services of Sucampo Pharmaceuticals
Table Products & Services of Ironwood Pharmaceuticals
Table Products & Services of Progenics Pharmaceuticals
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Chronic Idiopathic Constipation (CIC) Drugs Market Forecast (Million USD) by Region 2021f-2026f
Table Global Chronic Idiopathic Constipation (CIC) Drugs Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Chronic Idiopathic Constipation (CIC) Drugs Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Chronic Idiopathic Constipation (CIC) Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lubiprostone Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals & Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ambulatory Surgical Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long Term Care Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lubiprostone Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals & Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ambulatory Surgical Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long Term Care Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lubiprostone Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals & Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ambulatory Surgical Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long Term Care Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lubiprostone Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals & Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ambulatory Surgical Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long Term Care Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lubiprostone Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals & Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ambulatory Surgical Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long Term Care Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lubiprostone Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals & Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ambulatory Surgical Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long Term Care Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Actavis 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Chugai Pharmaceutical 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Ferring International Center 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Synergy Pharmaceuticals 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Pfizer 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of GlaxoSmithKline 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Roche Holding 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Sanofi 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Bayer 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Salix Pharmaceuticals 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Sucampo Pharmaceuticals 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Ironwood Pharmaceuticals 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Progenics Pharmaceuticals 2017-2020e
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lubiprostone Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals & Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ambulatory Surgical Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long Term Care Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lubiprostone Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals & Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ambulatory Surgical Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long Term Care Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lubiprostone Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals & Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ambulatory Surgical Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long Term Care Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lubiprostone Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals & Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ambulatory Surgical Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long Term Care Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lubiprostone Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals & Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ambulatory Surgical Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long Term Care Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lubiprostone Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals & Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ambulatory Surgical Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long Term Care Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Actavis 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Chugai Pharmaceutical 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Ferring International Center 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Synergy Pharmaceuticals 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Pfizer 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of GlaxoSmithKline 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Roche Holding 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Sanofi 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Bayer 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Salix Pharmaceuticals 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Sucampo Pharmaceuticals 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Ironwood Pharmaceuticals 2017-2020e
Figure Chronic Idiopathic Constipation (CIC) Drugs Sales Revenue (Million USD) of Progenics Pharmaceuticals 2017-2020e
